These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12447733

  • 1. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C.
    J Infect Dis; 2002 Dec 01; 186(11):1582-8. PubMed ID: 12447733
    [Abstract] [Full Text] [Related]

  • 2. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ, Zanamivir Family Study Group.
    N Engl J Med; 2000 Nov 02; 343(18):1282-9. PubMed ID: 11058672
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.
    Clin Ther; 2007 Aug 02; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A.
    J Infect; 2000 Jan 02; 40(1):42-8. PubMed ID: 10762110
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K.
    N Engl J Med; 1997 Sep 25; 337(13):874-80. PubMed ID: 9302301
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G, Gillissen A.
    Med Microbiol Immunol; 2002 Dec 25; 191(3-4):169-73. PubMed ID: 12458354
    [Abstract] [Full Text] [Related]

  • 7. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
    Kaiser L, Henry D, Flack NP, Keene O, Hayden FG.
    Clin Infect Dis; 2000 Mar 25; 30(3):587-9. PubMed ID: 10722450
    [Abstract] [Full Text] [Related]

  • 8. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.
    Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O.
    Pediatr Infect Dis J; 2000 May 25; 19(5):410-7. PubMed ID: 10819336
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T, Elliott M, Keene ON, Man CY.
    J Infect Dis; 1999 Aug 25; 180(2):254-61. PubMed ID: 10395837
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
    Calfee DP, Peng AW, Hussey EK, Lobo M, Hayden FG.
    Antivir Ther; 1999 Aug 25; 4(3):143-9. PubMed ID: 12731753
    [Abstract] [Full Text] [Related]

  • 11. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
    Johny AA, Clark A, Price N, Carrington D, Oakhill A, Marks DI.
    Bone Marrow Transplant; 2002 Jan 25; 29(2):113-5. PubMed ID: 11850704
    [Abstract] [Full Text] [Related]

  • 12. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb 25; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

  • 13. Influenza in the family.
    Wright P.
    N Engl J Med; 2000 Nov 02; 343(18):1331-2. PubMed ID: 11058679
    [No Abstract] [Full Text] [Related]

  • 14. Zanamivir: from drug design to the clinic.
    Elliott M.
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1885-93. PubMed ID: 11779388
    [Abstract] [Full Text] [Related]

  • 15. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE.
    Med Microbiol Immunol; 2002 Dec 29; 191(3-4):161-3. PubMed ID: 12458352
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patient perspective on zanamivir in the treatment of influenza.
    Bricaire F, Cohen JM, Jacquet M, Boucot I, Nicolas M, JAG Committee. Journée d'Actualites Grippe.
    Int J Clin Pract; 2002 Dec 29; 56(1):7-10. PubMed ID: 11831842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.